The results of superficial femoral, popliteal, and tibial artery stenting for peripheral vascular occlusive disease

Morgan III, Joe H.; Wall Jr., Charles E.; Christie III, D. Benjamin; Harvey, Richard L.; Solis, Maurice M.; Morgan, Joe H 3rd; Wall, Charles E Jr; Christie, D Benjamin
November 2005
American Surgeon;Nov/2005, Vol. 71 Issue 11, p905
Academic Journal
journal article
The purpose of this study was to evaluate the patentcy rates and physiological effectiveness of angioplasty and stenting as a primary therapy for superficial femoral (SFA), popliteal (POP), and tibial (TIB) arterial occlusive disease. Seventy-eight patients had stents placed in the infra-inguinal vessels between January 1, 2001, and July 31, 2004. We collected data on patient demographics, symptoms, as well as pre- and postprocedure ankle-brachial index (ABI) and angiographic findings. Patency rates at 6 months, 12 months, and 24 months were analyzed by life table methods. Thirty-one men and 47 women had a mean age of 68 years (range 36-94 years). Risk factors included diabetes in 50 per cent, hypertension in 79 per cent, smoking in 41 per cent, and end-stage renal disease in 10 per cent. The indications for intervention were claudication in 52 per cent and limb salvage in 48 per cent of patients. Stents were placed in the SFA in 54 patients (69%), in the POP in 15 patients (18%), and in the TIB artery in 6 patients (8%). Average follow-up was 11.2 months. The mean postprocedural increase in ABI was 0.29. The 6-month, 1-year, and 2-year primary patency rates were 83 per cent, 58 per cent, and 47 per cent, respectively. Limb salvage was achieved in 66 per cent of patients treated for limb-threatening ischemia. There was one major and three minor complications. Stenting of the infra-inguinal vessels has a low morbidity, high success rate, and acceptable patency and limb-salvage rates.


Related Articles

  • Abstracts, Hellenic Society of Nephrology.  // Kidney International;Jan1991, Vol. 39 Issue 1, p184 

    Presents several abstracts on nephrology. "Renal Pathology and Clinical Course of Silent Lupus Nephritis," by K. C. Siamopoulos, A. Drosos, F. Sotsiou, D. Psihos, M. Elisaf and H.M. Moutsopuolos; "Treatment of Lipid Abnormalities in Patients With Chronic Renal Failure," by M. Elisaf, G....

  • The Quiet Killer. O. Z., Mehmet // O, The Oprah Magazine;Oct2010, Vol. 11 Issue 10, p154 

    In this article, the author reports on chronic kidney disease (CKD), a life-threatening disease that afflicts millions of people in the U.S. CKD occurs when over the course of several months to years, the organs' tiny filters are progressively damaged. Diabetes and hypertension, together account...

  • The 10-Year Incidence of Renal Insufficiency in People With Type 1 Diabetes. Klein, Ronald; Klein, Barbara E.K.; Moss, Scot E.; Cruickshanks, Karen J.; Brazy, Peter C. // Diabetes Care;May99, Vol. 22 Issue 5, p743 

    Presents information on a study which described the 10-year decrease in estimated creatinine clearance and the incidence of renal insufficiency and end-stage renal disease in a cohort of people with type one diabetes. Research design and methods; Results; Conclusions.

  • End-stage renal disease attributable to diabetes mellitus. Perneger, Thomas V.; Brancati, Frederick L.; Whelton, Paul K.; Klag, Michael J.; Perneger, T V; Brancati, F L; Whelton, P K; Klag, M J // Annals of Internal Medicine;12/15/94, Vol. 121 Issue 12, p912 

    Objective: To determine the proportion of end-stage renal disease associated with diabetes mellitus in a biracial population, using population-attributable risk estimates.Design: Case-control study.Setting: Population-based study in Maryland, Virginia, West...

  • 359. Value of coronary angioplasty in renal insufficiency remains unclear. Matzkies, F.K.; Reinecke, H.; Regetmeier, A. // Kidney;May/Jun2002, Vol. 11 Issue 3, p118 

    Provides information on a study which assessed the effects of percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy. Methodology; Results; Conclusion.

  • Cholesterol crystal embolism: Diagnosis and treatment. Meyrier, A. // Kidney International;Apr2006, Vol. 69 Issue 8, p1308 

    Cholesterol crystal embolization (CCE) is a dreaded complication of radiology, vascular surgery, and/or anticoagulation in patients with atherosclerosis and ulcerated aortic plaques. It also represents a cause of early graft failure and of poor results of renal artery surgery. Crystals lodge in...

  • Aorto-Femoral Bypass: A Multicenter Retrospective Study of 281 Cases. Miyazaki, Keiko; Nishibe, Toshiya; Sata, Fumihiro; Kudo, Fabio A.; Flores, Jorge; Miyazaki, Yasumasa J.; Yasuda, Keishu // International Journal of Angiology (Springer Science & Business ;Spring2003, Vol. 12 Issue 2, p125 

    Aorto-femoral (A-F) bypass surgery has been performed commonly and safely as an interventional therapy for iliac arterial stenosis or obstruction. Recently, catheter intervention has increasingly replaced this modality. However, no consensus has been reached as to a lesion-specific treatment...

  • Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Matsubara, Takeshi; Abe, Hideharu; Arai, Hidenori; Nagai, Kojiro; Mima, Akira; Kanamori, Hiroshi; Sumi, Eriko; Takahashi, Toshikazu; Matsuura, Motokazu; Iehara, Noriyuki; Fukatsu, Atsushi; Kita, Toru; Doi, Toshio // Laboratory Investigation (00236837);Apr2006, Vol. 86 Issue 4, p357 

    Diabetic nephropathy is the leading cause of end-stage renal disease, and glomerular mesangial matrix expansion is the hallmark in diabetic nephropathy. However, the precise mechanism for the development of mesangial matrix expansion has remained unknown. The key component involved in mesangial...

  • Cumulative Risk, Age at Onset, and Sex-Specific Differences for Developing End-Stage Renal Disease in Young Patients With Type 1 Diabetes. Möllsten, Anna; Svensson, Maria; Waernbaum, Ingeborg; Berhan, Yonas; Schön, Staffan; Nyström, Lennarth; Arnqvist, Hans J.; Dahlquist, Gisela // Diabetes;Jul2010, Vol. 59 Issue 7, p1803 

    OBJECTIVE--This study aimed to estimate the current cumulative risk of end-stage renal disease (ESRD) due to diabetic nephropathy in a large, nationwide, population-based prospective type 1 diabetes cohort and specifically study the effects of sex and age at onset. RESEARCH DESIGN AND...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics